Searchable abstracts of presentations at key conferences in endocrinology

ea0099p485 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Diabetes mellitus in patients undergoing pancreatectomy (T3cDM): preliminary data analysis

Borrini Martina , Mele Chiara , Maroso Fabio , Pitino Rosa , Vimercati Davide , Romito Raffaele , Aimaretti Gianluca , Marzullo Paolo

Rationale and purpose: Glucose tolerance often changes in patients with pancreatic lesions and usually worsens after distal pancreatectomy; however, factors affecting interindividual variation in progression are unclear. Our study aimed to investigate the glyco-metabolic status in a series of patients undergoing pancreatic resection for treatment of benign or malignant lesions and risk factors involved in the developing T3cDM.Methods: We conducted an obs...

ea0081ep569 | Endocrine-Related Cancer | ECE2022

Novel pathogenetic mutation of MEN1 gene causing hyperparathyroidism, pancreatic glucagonoma, adrenal adenoma, and collagenomas

Pitino Rosa , Vimercati Davide , Pizzolitto Francesca , Mollero Edoardo Luigi Maria , Daffara Tommaso , Ferrero Alice , Boldorini Renzo , Caputo Marina , Prodam Flavia

Background: Multiple endocrine neoplasia type 1 (MEN1) is a rare hereditary autosomal dominant tumor syndrome caused by inactivating mutations of the tumor suppressor gene MEN1 which encodes the protein menin. It is characterized by the occurrence of tumors involving two or more endocrine glands, primarily parathyroid, entero-pancreatic, and anterior pituitary, as well as non-endocrine neoplasms. Glucagonomas occur in fewer than 3% of patients with MEN1, causing hyper...

ea0099p267 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Acquired partial lipodystrophy: leptin and glucose blood levels in a pregnant patient

Romanisio Martina , Bighetti Leonardo , Daffara Tommaso , Ciamparini Carola , Vimercati Davide , Pitino Rosa , Pelosini Caterina , Aimaretti Gianluca , Caputo Marina , Prodam Flavia

Lipodystrophy syndromes are a rare and heterogeneous disease characterized by loss of subcutaneous adipose tissue, deposition of fat in ectopic areas, and consequently metabolic impairment, and its recognition is based on physical examination and clinical history. Because of the complexity of the disease, pregnancy represents a dainty and challenging event, still understudied. Here we report a case of a 28 year-old Caucasian female followed for type 2 diabetes and hypertriglyc...

ea0099p366 | Reproductive and Developmental Endocrinology | ECE2024

“Brief intelligence test” questionnaire in klinefelter syndrome: may words improve diagnosis?

Vimercati Davide , Marinelli Lorenzo , Cagnina Serena , Daffara Tommaso , Bichiri Andrea , Di Bisceglie Cataldo , Motta Giovanna , Lanfranco Fabio , Zavattaro Marco

Background: The clinical burden of Klinefelter Syndrome (KS) is not limited to the impairment of gonadal function and an increased prevalence of cardio-metabolic, endocrinological and oncological diseases, but also involve several cognitional, behavioural and psychological issues. Because of the wide heterogeneity in clinical phenotype, the diagnosis of KS is still challenging, resulting in a significant number of patients to remain undiagnosed or to have a late diagnosis. Ver...

ea0081p673 | Pituitary and Neuroendocrinology | ECE2022

Transition in endocrinology: predictors of drop-out in a heterogeneous population during long-term follow-up

Romanisio Martina , Brasili Sara , Daffara Tommaso , Ferrero Alice , Vimercati Davide , Pizzolitto Francesca , Pitino Rosa , Luigi Maria Mollero Edoardo , Zavattaro Marco , Bellone Simonetta , Caputo Marina , Aimaretti Gianluca , Prodam Flavia

Aim: To evaluate: 1) clinical and epidemiological characteristics of outpatients transitioned from Pediatrics Endocrine (PED) to Adult Endocrine Department (AED) in a tertiary Centre; 2) transition process characteristics, and predictive factors of drop-out.Patients and methods: Demographic, clinical, and transition features of 170 consecutive patients with paediatric onset of chronic endocrine or metabolic disease (excluded type 1 diabetes) who transiti...

ea0099ep510 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Type 2 diabetes and cancer: phenotyping of patients followed in a tertiary diabetic centre

Luigi Maria Mollero Edoardo , Ciamparini Carola , Vimercati Davide , Bighetti Leonardo , Marsan Giulia , Scotti Lorenza , Marzullo Paolo , Caputo Marina , Aimaretti Gianluca , Prodam Flavia

Background: Data on the relationship between type 2 diabetes (T2D) and cancer consistently suggests the involvement of metabolic mechanisms such as inflammation, obesity, and glucose alteration. These mechanisms, including the activation of factors like IGF-1 or m-TOR, may influence the development of cancer.Aim: Our study had two main objectives. Firstly, we aimed to investigate the relationship between specific identifiable factors associated with T2D ...